Tapasin - The star of the show in HLA-I maturation
Författare
Summary, in English
In this thesis I have studied HLA-I maturation, and tapasin in particular, both biochemically and in tumor material. The first paper is a study of HLA-I folding in the presence and absence of a part of recombinant tapasin (tpn1-87). Here we studied how different HLA-I allomorphs depend on tapasin and the influence of peptide length. This is the first study where a large number of HLA-I allomorphs have been simultaneously analyzed for tapasin facilitation. We found that the influence of peptide length for the different allomorphs increased with their tapasin dependence. In paper II and III we studied HLA-I, tapasin and other APM proteins in tumor sections and cell lines of glioblastoma multiforme (GBM). In tumors APM proteins are commonly downregulated as a strategy to evade the immune system. We also found the APM proteins in our tumor material to be highly dysregulated with strongly linked HLAI
and tapasin expression. In tumor tissue sections HLA-I and tapasin expression also correlated with survival of GBM patients. High resolution HLA-I typing allowed us to study the HLA-I allomorphs expressed in GBM patients and also each allomorph’s tapasin dependence. We found that GBM patients display HLA-I allomorph profiles with mixed dependency of tapasin, similar as in a healthy cohort. In addition we show that tapasin deficient cells present suboptimally loaded HLA-I molecules on the cell surface. By exogenous addition of high affinity peptides we were able to increase the stability of presented HLA-A*02:01 molecules. The tapasin dependency of each allomorph as well as composition and proportions of HLA-I allomorphs presented on the cell surface is of importance not only for
mechanistic understanding but also for immunotherapy settings in different diseases. GBM is an aggressive brain tumor with poor prognosis and there are high demands for new and more effective treatments. We propose individualized immunotherapy protocols where tapasin expression and tapasin dependency of allomorphs expressed in each patient are taken into consideration to improve the selection of peptide:HLA-I combinations for peptide vaccines.
Avdelning/ar
Publiceringsår
2015
Språk
Engelska
Publikation/Tidskrift/Serie
Lund University Faculty of Medicine Doctoral Dissertation Series
Volym
2015:28
Fulltext
Dokumenttyp
Doktorsavhandling
Förlag
Antigen Presentation
Ämne
- Pharmacology and Toxicology
Nyckelord
- Tapasin
- HLA-I
- tumor
- antigen presentation
Status
Published
Forskningsgrupp
- Antigen Presentation
Handledare
ISBN/ISSN/Övrigt
- ISSN: 1652-8220
- ISBN: 978-91-7619-107-1
Försvarsdatum
20 mars 2015
Försvarstid
09:00
Försvarsplats
Belfrage Hall, BMC D15, Klinikgatan 32, Lund
Opponent
- Stefan Stevanovic (Prof.)